{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:37:35Z","timestamp":1790725055088,"version":"4.1.0"},"reference-count":49,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_cclm-2022-0778_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Measurement of high-sensitivity (hs) cardiac troponin (cTn) T and I is widely studied for cardiac assessment of stable populations. Recent data suggest clinical and prognostic discrepancies between both hs-cTn. We aimed at reviewing published studies with respect to underlying causes and clinical implications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2022-0778_abs_002\">\n                    <jats:title>Content<\/jats:title>\n                    <jats:p>We summarized current evidence on release and clearance mechanisms of cTnT and I, and on preanalytical and assay-related issues potentially portending to differences in measured concentrations. We also performed a systematic review of outcome studies comparing both hs-cTn in the general population, patients with congestive heart failure, stable coronary artery disease and atrial fibrillation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_cclm-2022-0778_abs_003\">\n                    <jats:title>Summary and outlook<\/jats:title>\n                    <jats:p>For the interpretation of concentrations of hs-cTnT, stronger association with renal dysfunction compared to hs-cTnI should be considered. Hs-cTnT also appears to be a stronger indicator of general cardiovascular morbidity and all-cause mortality. Hs-cTnI concentrations tend to be more sensitive to coronary artery disease and ischemic outcomes. These findings apparently reflect variations in the mechanisms of cardiac affections resulting in cTn release. Whether these differences are of clinically relevance remains to be elucidated. However, having the option of choosing between either hs-cTn might represent an option for framing individualized cardiac assessment in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/cclm-2022-0778","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T01:50:46Z","timestamp":1669341046000},"page":"380-387","source":"Crossref","is-referenced-by-count":30,"title":["Differences between high-sensitivity cardiac troponin T and I in stable populations: underlying causes and clinical implications"],"prefix":"10.1515","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8806-5778","authenticated-orcid":false,"given":"Kai M.","family":"Eggers","sequence":"first","affiliation":[{"name":"Department of Medical Sciences , Cardiology , Uppsala University , Uppsala , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Hammarsten","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry and Transfusion Medicine , Sahlgrenska University , G\u00f6teborg , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertil","family":"Lindahl","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences and Uppsala Clinical Research Center , Uppsala University , Uppsala , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"2023013019295659413_j_cclm-2022-0778_ref_001","doi-asserted-by":"crossref","unstructured":"Thygesen, K, Alpert, JS, Jaffe, AS, Chaitman, BR, Bax, JJ, Morrow, DA, et al.. Fourth universal definition of myocardial infarction (2018). J\u00a0Am Coll Cardiol 2018;72:2231\u201364. https:\/\/doi.org\/10.1016\/j.jacc.2018.08.1038.","DOI":"10.1016\/j.jacc.2018.08.1038"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_002","doi-asserted-by":"crossref","unstructured":"Eggers, KM, Lindahl, B. Application of cardiac troponin in cardiovascular diseases other than acute coronary syndrome. Clin Chem 2017;63:223\u201335. https:\/\/doi.org\/10.1373\/clinchem.2016.261495.","DOI":"10.1373\/clinchem.2016.261495"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_003","doi-asserted-by":"crossref","unstructured":"Willeit, P, Welsh, P, Evans, JDW, Tschiderer, L, Boachie, C, Jukema, JW, et al.. High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154, 052 participants. J Am Coll Cardiol 2017;70:558\u201368. https:\/\/doi.org\/10.1016\/j.jacc.2017.05.062.","DOI":"10.1016\/j.jacc.2017.05.062"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_004","doi-asserted-by":"crossref","unstructured":"Shah, KS, Maisel, AS, Fonarow, GC. Troponin in heart failure. Heart Fail Clin 2018;14:57\u201364. https:\/\/doi.org\/10.1016\/j.hfc.2017.08.007.","DOI":"10.1016\/j.hfc.2017.08.007"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_005","doi-asserted-by":"crossref","unstructured":"Omland, T, White, HD. State of the art: blood biomarkers for risk stratification in patients with stable ischemic heart disease. Clin Chem 2017;63:165\u201376. https:\/\/doi.org\/10.1373\/clinchem.2016.255190.","DOI":"10.1373\/clinchem.2016.255190"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_006","doi-asserted-by":"crossref","unstructured":"Hijazi, Z, Oldgren, J, Siegbahn, A, Wallentin, L. Application of biomarkers for risk stratification in patients with atrial fibrillation. Clin Chem 2017;63:152\u201364. https:\/\/doi.org\/10.1373\/clinchem.2016.255182.","DOI":"10.1373\/clinchem.2016.255182"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_007","doi-asserted-by":"crossref","unstructured":"Potter, JD. Preparation of troponin and its subunits. Methods Enzymol 1982;85 Pt B:241\u201363.","DOI":"10.1016\/0076-6879(82)85024-6"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_008","doi-asserted-by":"crossref","unstructured":"Starnberg, K, Frid\u00e9n, V, Muslimovic, A, Ricksten, SE, Nystr\u00f6m, S, Forsgard, N, et al.. A possible mechanism behind faster clearance and higher peak concentrations of cardiac troponin I compared with troponin T in acute myocardial infarction. Clin Chem 2020;66:333\u201341. https:\/\/doi.org\/10.1093\/clinchem\/hvz003.","DOI":"10.1093\/clinchem\/hvz003"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_009","doi-asserted-by":"crossref","unstructured":"Aw, TC, Huang, WT, Le, TT, Pua, CJ, Ang, B, Phua, SK, et al.. High-sensitivity cardiac troponins in cardio-healthy subjects: a cardiovascular magnetic resonance imaging study. Sci Rep 2018;8:15409. https:\/\/doi.org\/10.1038\/s41598-018-33850-9.","DOI":"10.1038\/s41598-018-33850-9"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_010","doi-asserted-by":"crossref","unstructured":"Jia, X, Sun, W, Hoogeveen, RC, Nambi, V, Matsushita, K, Folsom, AR, et al.. High-sensitivity troponin I and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study. Circulation 2019;139:2642\u201353. https:\/\/doi.org\/10.1161\/circulationaha.118.038772.","DOI":"10.1161\/CIRCULATIONAHA.118.038772"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_011","doi-asserted-by":"crossref","unstructured":"Welsh, P, Preiss, D, Hayward, C, Shah, ASV, McAllister, D, Briggs, A, et al.. Cardiac troponin T and troponin I in the general population. Circulation 2019;139:2754\u201364. https:\/\/doi.org\/10.1161\/circulationaha.118.038529.","DOI":"10.1161\/CIRCULATIONAHA.118.038529"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_012","doi-asserted-by":"crossref","unstructured":"Lyngbakken, MN, Aagaard, EN, Kvisvik, B, Berge, T, Pervez, MO, Brynildsen, J, et al.. Cardiac troponin I and T are associated with left ventricular function and structure: data from the akershus cardiac examination 1950 study. Clin Chem 2020;66:567\u201378. https:\/\/doi.org\/10.1093\/clinchem\/hvaa023.","DOI":"10.1093\/clinchem\/hvaa023"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_013","doi-asserted-by":"crossref","unstructured":"Tveit, SH, Myhre, PL, Hanssen, TA, Forsdahl, SH, Iqbal, A, Omland, T, et al.. Cardiac troponin I and T for ruling out coronary artery disease in suspected chronic coronary syndrome. Sci Rep 2022;12:945. https:\/\/doi.org\/10.1038\/s41598-022-04850-7.","DOI":"10.1038\/s41598-022-04850-7"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_014","doi-asserted-by":"crossref","unstructured":"van der Linden, N, Klinkenberg, LJJ, Bekers, O, Loon, LJCV, Dieijen-Visser, MPV, Zeegers, MP, et al.. Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: a meta-analysis. Medicine (Baltimore) 2016;95:e5703. https:\/\/doi.org\/10.1097\/md.0000000000005703.","DOI":"10.1097\/MD.0000000000005703"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_015","doi-asserted-by":"crossref","unstructured":"Aimo, A, Georgiopoulos, G, Panichella, G, Vergaro, G, Passino, C, Emdin, M, et al.. High-sensitivity troponins for outcome prediction in the general population: a systematic review and meta-analysis. Eur J Intern Med 2022;98:61\u20138. https:\/\/doi.org\/10.1016\/j.ejim.2022.01.012.","DOI":"10.1016\/j.ejim.2022.01.012"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_016","doi-asserted-by":"crossref","unstructured":"Bay, B, Go\u00dfling, A, Blaum, CM, Kroeger, F, Koppe, L, Lorenz, T, et al.. Association of high-sensitivity troponin T and I blood concentrations with all-cause mortality and cardiovascular outcome in stable patients-results from the INTERCATH cohort. J\u00a0Am Heart Assoc 2022;11:e024516. https:\/\/doi.org\/10.1161\/jaha.121.024516.","DOI":"10.1161\/JAHA.121.024516"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_017","doi-asserted-by":"crossref","unstructured":"Omland, T, Pfeffer, MA, Solomon, SD, de Lemos, JA, R\u00f8sj\u00f8, H, \u0160altyt\u0117 Benth, J, et al.. Prognostic value of cardiac troponin I\u00a0measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol 2013;61:1240\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2012.12.026.","DOI":"10.1016\/j.jacc.2012.12.026"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_018","doi-asserted-by":"crossref","unstructured":"Hijazi, Z, Siegbahn, A, Andersson, U, Lindahl, B, Granger, CB, Alexander, JH, et al.. Comparison of cardiac troponins I and T\u00a0measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. Clin Chem 2015;61:368\u201378. https:\/\/doi.org\/10.1373\/clinchem.2014.226936.","DOI":"10.1373\/clinchem.2014.226936"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_019","doi-asserted-by":"crossref","unstructured":"R\u00f8sj\u00f8, H, Hijazi, Z, Omland, T, Westerbergh, J, Lyngbakken, MN, Alexander, JH, et al.. Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial. J Intern Med 2020;288:248\u201359. https:\/\/doi.org\/10.1111\/joim.13072.","DOI":"10.1111\/joim.13072"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_020","doi-asserted-by":"crossref","unstructured":"Katrukha, IA, Katrukha, AG. Myocardial injury and the release of troponins I and T in the blood of patients. Clin Chem 2021;67:124\u201330. https:\/\/doi.org\/10.1093\/clinchem\/hvaa281.","DOI":"10.1093\/clinchem\/hvaa281"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_021","doi-asserted-by":"crossref","unstructured":"Samaha, E, Avila, A, Helwani, MA, Ben Abdallah, A, Jaffe, AS, Scott, MG, et al.. High-sensitivity cardiac troponin after cardiac stress test: a systematic review and meta-analysis. J Am Heart Assoc 2019;8:e008626. https:\/\/doi.org\/10.1161\/jaha.118.008626.","DOI":"10.1161\/JAHA.118.008626"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_022","doi-asserted-by":"crossref","unstructured":"Solecki, K, Dupuy, AM, Kuster, N, Leclercq, F, Gervasoni, R, Macia, JC, et al.. Kinetics of high-sensitivity cardiac troponin T or troponin I\u00a0compared to creatine kinase in patients with revascularized acute myocardial infarction. Clin Chem Lab Med 2015;53:707\u201314. https:\/\/doi.org\/10.1515\/cclm-2014-0475.","DOI":"10.1515\/cclm-2014-0475"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_023","doi-asserted-by":"crossref","unstructured":"Laugaudin, G, Kuster, N, Petiton, A, Leclercq, F, Gervasoni, R, Macia, JC, et al.. Kinetics of high-sensitivity cardiac troponin T and I differ in patients with ST-segment elevation myocardial infarction treated by primary coronary intervention. Eur Heart J Acute Cardiovasc Care 2016;5:354\u201363. https:\/\/doi.org\/10.1177\/2048872615585518.","DOI":"10.1177\/2048872615585518"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_024","doi-asserted-by":"crossref","unstructured":"Kragten, JA, Hermens, WT, van Dieijen-Visser, MP. Cumulative troponin T release after acute myocardial infarction. Influence of reperfusion. Eur J Clin Chem Clin Biochem 1997;35:459\u201367. https:\/\/doi.org\/10.1515\/cclm.1997.35.6.459.","DOI":"10.1515\/cclm.1997.35.6.459"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_025","doi-asserted-by":"crossref","unstructured":"Hammarsten, O, Mair, J, M\u00f6ckel, M, Lindahl, B, Jaffe, AS. Possible mechanisms behind cardiac troponin elevations. Biomarkers 2018;23:725\u201334. https:\/\/doi.org\/10.1080\/1354750x.2018.1490969.","DOI":"10.1080\/1354750X.2018.1490969"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_026","doi-asserted-by":"crossref","unstructured":"Bjurman, C, Petzold, M, Venge, P, Farbemo, J, Fu, ML, Hammarsten, O. High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease. Clin Biochem 2015;48:302\u20137. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.01.008.","DOI":"10.1016\/j.clinbiochem.2015.01.008"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_027","doi-asserted-by":"crossref","unstructured":"deFilippi, CR, Herzog, CA. Interpreting cardiac biomarkers in the setting of chronic kidney disease. Clin Chem 2017;63:59\u201365. https:\/\/doi.org\/10.1373\/clinchem.2016.254748.","DOI":"10.1373\/clinchem.2016.254748"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_028","doi-asserted-by":"crossref","unstructured":"Parikh, RH, Seliger, SL, deFilippi, CR. Use and interpretation of high sensitivity cardiac troponins in patients with chronic kidney disease with and without acute myocardial infarction. Clin Biochem 2015;48:247\u201353. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.01.004.","DOI":"10.1016\/j.clinbiochem.2015.01.004"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_029","doi-asserted-by":"crossref","unstructured":"Clerico, A, Zaninotto, M, Passino, C, Padoan, A, Migliardi, M, Plebani, M. High-sensitivity methods for cardiac troponins: the mission is not over yet. Adv Clin Chem 2021;103:215\u201352.","DOI":"10.1016\/bs.acc.2020.08.009"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_030","doi-asserted-by":"crossref","unstructured":"Wens, SC, Schaaf, GJ, Michels, M, Kruijshaar, ME, van Gestel, TJ, In \u2019t Groen, S, et al.. Elevated plasma cardiac troponin T levels caused by skeletal muscle damage in Pompe disease. Circ Cardiovasc Genet 2016;9:6\u201313. https:\/\/doi.org\/10.1161\/circgenetics.115.001322.","DOI":"10.1161\/CIRCGENETICS.115.001322"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_031","doi-asserted-by":"crossref","unstructured":"Schmid, J, Liesinger, L, Birner-Gruenberger, R, Stojakovic, T, Scharnagl, H, Dieplinger, B, et al.. Elevated cardiac troponin T in patients with skeletal myopathies. J Am Coll Cardiol 2018;71:1540\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2018.01.070.","DOI":"10.1016\/j.jacc.2018.01.070"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_032","doi-asserted-by":"crossref","unstructured":"Giannitsis, E, Mueller, C, Katus, HA. Skeletal myopathies as a non-cardiac cause of elevations of cardiac troponin concentrations. Diagnosis (Berl) 2019;6:189\u2013201. https:\/\/doi.org\/10.1515\/dx-2019-0045.","DOI":"10.1515\/dx-2019-0045"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_033","doi-asserted-by":"crossref","unstructured":"Clerico, A, Padoan, A, Zaninotto, M, Passino, C, Plebani, M. Clinical relevance of biological variation of cardiac troponins. Clin Chem Lab Med 2020;59:641\u201352. https:\/\/doi.org\/10.1515\/cclm-2020-1433.","DOI":"10.1515\/cclm-2020-1433"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_034","doi-asserted-by":"crossref","unstructured":"Klinkenberg, LJ, Wildi, K, van der Linden, N, Kouw, IW, Niens, M, Twerenbold, R, et al.. Diurnal rhythm of cardiac troponin: consequences for the diagnosis of acute myocardial infarction. Clin Chem 2016;62:1602\u201311. https:\/\/doi.org\/10.1373\/clinchem.2016.257485.","DOI":"10.1373\/clinchem.2016.257485"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_035","unstructured":"High-Sensitivity* Cardiac Troponin I and T Assay Analytical Characteristics Designated by Manufacturer. IFCC committee on clinical applications of cardiac bio-markers (C-CB) v122019. https:\/\/www.ifcc.org\/media\/478231\/high-sensitivity-cardiac-troponin-i-and-t-assay-analytical-characteristics-designated-by-manufacturer-v122019.pdf [Accessed 12th Jun 2022]."},{"key":"2023013019295659413_j_cclm-2022-0778_ref_036","doi-asserted-by":"crossref","unstructured":"Welsh, P, Preiss, D, Shah, ASV, McAllister, D, Briggs, A, Boachie, C, et al.. Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort. Clin Chem 2018;64:1607\u201316. https:\/\/doi.org\/10.1373\/clinchem.2018.292086.","DOI":"10.1373\/clinchem.2018.292086"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_041","doi-asserted-by":"crossref","unstructured":"Pretorius, CJ, Ungerer, JP. Improved diagnostic performance of high-sensitivity cardiac troponin assays is an artifact of censored data. Clin Chem 2016;62:1654\u20137. https:\/\/doi.org\/10.1373\/clinchem.2016.262634.","DOI":"10.1373\/clinchem.2016.262634"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_037","doi-asserted-by":"crossref","unstructured":"Dallmeier, D, Denkinger, M, Peter, R, Rapp, K, Jaffe, AS, Koenig, W, et al.. Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study. Clin Chem 2015;61:389\u201399. https:\/\/doi.org\/10.1373\/clinchem.2014.230839.","DOI":"10.1373\/clinchem.2014.230839"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_038","doi-asserted-by":"crossref","unstructured":"Gohar, A, Chong, JPC, Liew, OW, den Ruijter, H, de Kleijn, DPV, Sim, D, et al.. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction. Eur J Heart Fail 2017;19:1638\u201347. https:\/\/doi.org\/10.1002\/ejhf.911.","DOI":"10.1002\/ejhf.911"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_039","doi-asserted-by":"crossref","unstructured":"Jansen, H, J\u00e4nsch, A, Breitling, LP, Hoppe, L, Dallmeier, D, Schmucker, R, et al.. Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD\u00a0\u2013 a comparative analysis from the KAROLA study. Int J Cardiol 2018;250:247\u201352. https:\/\/doi.org\/10.1016\/j.ijcard.2017.08.062.","DOI":"10.1016\/j.ijcard.2017.08.062"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_040","doi-asserted-by":"crossref","unstructured":"Omland, T, de Lemos, JA, Sabatine, MS, Christophi, CA, Rice, MM, Jablonski, KA, et al.. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361:2538\u201347. https:\/\/doi.org\/10.1056\/nejmoa0805299.","DOI":"10.1056\/NEJMoa0805299"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_042","doi-asserted-by":"crossref","unstructured":"Evans, JDW, Dobbin, SJH, Pettit, SJ, Di Angelantonio, E, Willeit, P. High-sensitivity cardiac troponin and new-onset heart failure: a\u00a0systematic review and meta-analysis of 67,063 patients with 4,165 incident heart failure events. JACC Heart Fail 2018;6:187\u201397. https:\/\/doi.org\/10.1016\/j.jchf.2017.11.003.","DOI":"10.1016\/j.jchf.2017.11.003"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_043","doi-asserted-by":"crossref","unstructured":"Nagarajan, V, Hernandez, AV, Tang, WH. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart 2012;98:1778\u201386. https:\/\/doi.org\/10.1136\/heartjnl-2012-301779.","DOI":"10.1136\/heartjnl-2012-301779"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_044","doi-asserted-by":"crossref","unstructured":"Li, Y, Pei, H, Zhou, C. Cardiac troponins predict adverse clinical outcomes in stable coronary artery disease: a dose-response meta-analysis of prospective studies. Biomarkers 2019;24:556\u201365. https:\/\/doi.org\/10.1080\/1354750x.2019.1606277.","DOI":"10.1080\/1354750X.2019.1606277"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_045","doi-asserted-by":"crossref","unstructured":"Sepehri Shamloo, A, Arya, A, Darma, A, Nedios, S, D\u00f6ring, M, Bollmann, A, et al.. Atrial fibrillation: is there a role for cardiac troponin? Diagnosis (Berl) 2020;8:295\u2013303. https:\/\/doi.org\/10.1515\/dx-2019-0072.","DOI":"10.1515\/dx-2019-0072"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_046","doi-asserted-by":"crossref","unstructured":"Provid\u00eancia, R, Paiva, L, Faustino, A, Botelho, A, Trigo, J, Casalta-Lopes, J, et al.. Cardiac troponin I: prothrombotic risk marker in non-valvular atrial fibrillation. Int J Cardiol 2013;167:877\u201382. https:\/\/doi.org\/10.1016\/j.ijcard.2012.01.093.","DOI":"10.1016\/j.ijcard.2012.01.093"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_047","doi-asserted-by":"crossref","unstructured":"Fan, Y, Zhao, X, Li, X, Li, N, Hu, X. Cardiac troponin and adverse outcomes in atrial fibrillation: a meta-analysis. Clin Chim Acta 2018;477:48\u201352. https:\/\/doi.org\/10.1016\/j.cca.2017.11.040.","DOI":"10.1016\/j.cca.2017.11.040"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_048","doi-asserted-by":"crossref","unstructured":"Hammarsten, O, Ljungqvist, P, Redfors, B, Wernbom, M, Widing, H, Lindahl, B, et al.. The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients. Clin Chim Acta 2022;527:33\u20137. https:\/\/doi.org\/10.1016\/j.cca.2021.12.030.","DOI":"10.1016\/j.cca.2021.12.030"},{"key":"2023013019295659413_j_cclm-2022-0778_ref_049","doi-asserted-by":"crossref","unstructured":"Eggers, KM, Hammarsten, O, Aldous, SJ, Cullen, L, Greenslade, JH, Lindahl, B, et al.. Diagnostic and prognostic performance of the ratio between high-sensitivity cardiac troponin I and troponin T in patients with chest pain. PLoS One 2022;17:e0276645. https:\/\/doi.org\/10.1371\/journal.pone.0276645.","DOI":"10.1371\/journal.pone.0276645"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2022-0778\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2022-0778\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T14:34:21Z","timestamp":1675089261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2022-0778\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,11,24]]},"published-print":{"date-parts":[[2023,2,23]]}},"alternative-id":["10.1515\/cclm-2022-0778"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2022-0778","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]}}}